SMMT
Summit Therapeutics PLC
18.00$
+3.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 93.8% | 93.5% | 92.4% | 96.2% | 97.5% | 97.3% | 96.6% | 94.2% | 94.2% | 95.9% | 95.2% | 95.8% | |
| 10.9% | 35.2% | 34.7% | 8.3% | 18.6% | 24.1% | 55.1% | 91.1% | 91.1% | 30.0% | 16.4% | 55.8% | |
| 91.1% | 91.8% | 88.6% | 95.2% | 96.8% | 94.7% | 94.1% | 91.1% | – | 95.0% | 92.4% | 91.8% | |
| 0.4% | 0.4% | 0.5% | 0.3% | 0.1% | 0.1% | – | – | – | – | – | – | |
| 2.8% | 1.5% | 0.2% | – | 0.2% | – | – | – | – | – | – | – | |
| 0.8% | 0.9% | 1.1% | 0.5% | 0.4% | 0.4% | 0.5% | 0.8% | 0.8% | 0.3% | 0.3% | 0.3% | |
| 54.5% | 61.7% | 75.0% | 42.9% | 12.9% | 10.7% | 10.3% | 26.5% | 26.5% | 12.3% | 15.7% | 16.2% | |
| 52.1% | 10.1% | 13.3% | 41.0% | 11.7% | 9.6% | 9.1% | 24.8% | 24.8% | 9.7% | 12.9% | 13.8% | |
| 47.0% | 1.4% | 2.1% | 30.3% | 5.6% | 0.9% | 0.9% | 1.0% | – | 0.5% | 0.5% | 0.5% | |
| 1.5% | 1.3% | 3.6% | 1.0% | 0.6% | 1.1% | 1.3% | 8.5% | 8.5% | 2.7% | 4.3% | 3.0% | |
| 55.7% | 62.3% | 71.0% | – | – | – | – | – | – | – | – | – | |
| 45.5% | 38.3% | 25.0% | 57.1% | 87.1% | 89.3% | 89.7% | 73.5% | 73.5% | 87.7% | 84.3% | 83.8% | |
| -437.9% | -489.4% | -586.4% | -320.9% | -229.4% | -278.9% | -332.8% | -792.8% | -792.8% | -305.4% | -383.4% | -358.9% | |
| 388.5% | 436.2% | 498.3% | 262.1% | 189.4% | 211.9% | 248.3% | 382.1% | 284.4% | 137.5% | 157.8% | 103.5% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.